US equities |
MU $983.23 ▲+5.86% META $612.49 ▼-1.24% GOOGL $324.89 ▲+1.34% NVDA $215.38 ▼-1.17% MSFT $531.01 ▼-0.06% TSLA $404.22 ▼-0.80% SPCX $145.23 ▼-2.25% SNDK $1,404.77 ▲+7.66%
FinancialContent

Latest News about NASDAQ:ENLV

Recent news which mentions NASDAQ:ENLV

ENLV Stock Earnings: Enlivex Therapeutics Misses EPS for Q4 2023
Tickers ENLV
Tags Earnings Reports Market News ENLV
From InvestorPlace
A Novel Immunotherapy That Could Bring Hope To Millions Of Sepsis Patients Received MultiCountry Clearance For Expanded Clinical Trial
Tickers ARDS ENLV MRK
Tags NASDAQ:ENLV
From News Direct
What's Next For Cell Therapy In Oncology? Enlivex (NASDAQ: ENLV) Says It Has The Answers
Tickers BLUE ENLV FATE NKTX
Tags NASDAQ:ENLV
From News Direct
First Patients Dosed in Phase I/II Trial of Enlivex’s Off-the-Shelf Cell Therapy Candidate, AllocetraTM
Tickers ENLV MRK NVS
Tags NASDAQ:ENLV
From News Direct
Israeli Ministry Of Health Clears Way For Human Trials Of AllocetraTM, A Proprietary Off-the-Shelf Immunotherapy For Solid Tumors
Tickers BMY ENLV MRK
Tags NASDAQ:ENLV
From News Direct